Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:935

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2005;112:935.)
© 2005 American Heart Association, Inc.

Issue Highlights


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    REAL-TIME THREE-DIMENSIONAL ECHOCARDIOGRAPHY: A NOVEL TECHNIQUE TO QUANTIFY GLOBAL LEFT VENTRICULAR MECHANICAL DYSSYNCHRONY, by Kapetanakis et al.
 
Left ventricular (LV) dyssynchrony is recognized as being an important contributor to LV dysfunction in patients with wide QRS complexes. Optimal evaluation of patients with dyssynchrony is uncertain, and various techniques have been described to identify appropriate candidates for cardiac resynchronization therapy (CRT) and to optimize settings after implantation. Kapetanakis et al describe a real-time 3-dimensional echocardiography technique in which global and regional volume and function are assessed in 89 healthy volunteers and 174 patients with and without LV dysfunction. A dyssynchrony index of the entire LV is derived that increases with worsening LV function irrespective of QRS duration. In 26 patients treated with CRT, the dyssynchrony index improves, and this correlates with reverse remodeling. This real-time, 3-dimensional, echo technique may help to quantify objectively the degree of dyssynchrony, direct CRT settings, and identify a larger group of patients with dyssynchrony in the absence of increased QRS duration. See p 992.


*    CONTRIBUTION OF CYCLOOXYGENASE-2 TO ELEVATED BIOSYNTHESIS OF THROMBOXANE A2 AND PROSTACYCLIN IN CIGARETTE SMOKERS, by McAdam et al.
 
In recent months, we have experienced an intense and fierce debate about the cardiovascular safety of COX-2 inhibitors. One of the issues in this context is their effects on the biosynthesis of prostaglandins. In this issue of Circulation, McAdam et al report on the effects of rofecoxib at a high dose on the biosynthesis of thromboxane A2 and prostacyclin in smokers and nonsmokers. Prostacyclin metabolites were increased in smokers and were reduced by rofecoxib; this also occurred to some degree in nonsmokers. Furthermore, the metabolites of thromboxane were increased in smokers and reduced by rofecoxib in smokers . . . [Full Text of this Article]


Related Articles:

Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?
Jack C.J. Sun, Mark A. Crowther, Theodore E. Warkentin, Andre Lamy, and Kevin H.T. Teoh
Circulation 2005 112: e85-e90. [Extract] [Full Text]

Prinzmetal Angina in an Adolescent: Adjunctive Role of Tissue Synchronization Imaging
D. Byron Holt, Gautam K. Singh, Edward K. Rhee, Joseph Billadello, and Achiahu Ludomirsky
Circulation 2005 112: e91-e92. [Extract] [Full Text]

Visualization of Regional Left Ventricular Mechanical Delay by Tissue Synchronization Imaging in Heart Failure Patients With Wide and Narrow QRS Complexes Undergoing Cardiac Resynchronization Therapy
Cheuk-Man Yu, Qing Zhang, and Jeffrey Wing-Hong Fung
Circulation 2005 112: e93-e95. [Extract] [Full Text]

Adult Patient With Isolated Noncompaction of Ventricular Myocardium
Tomoya Kaneda, Masami Shimizu, Hidekazu Ino, Hidenobu Terai, Noboru Fujino, Katsuharu Uchiyama, Tomohito Mabuchi, Tetsuo Konno, Takashi Fujita, Eichi Masuda, Hiromasa Kato, Akira Funada, Hiroshi Mabuchi, and Hiroko Ikeda
Circulation 2005 112: e96-e97. [Extract] [Full Text]

Inside the FDA: The Business and Politics Behind the Drugs We Take and the Food We Eat
Elliott M. Antman
Circulation 2005 112: e98. [Extract] [Full Text]

Letter Regarding Article by Nallamothu et al, "Times to Treatment in Transfer Patients Undergoing Primary Percutaneous Coronary Intervention in the United States" Response
Bruce R. Brodie, Cindy L. Grines, Gregg W. Stone, Brahmajee K. Nallamothu, Eric R. Bates, Jeph Herrin, Yongfei Wang, Elizabeth H. Bradley, and Harlan M. Krumholz
Circulation 2005 112: e99-e100. [Extract] [Full Text]

Real-Time Three-Dimensional Echocardiography: A Novel Technique to Quantify Global Left Ventricular Mechanical Dyssynchrony
S. Kapetanakis, M.T. Kearney, A. Siva, N. Gall, M. Cooklin, and M.J. Monaghan
Circulation 2005 112: 992-1000. [Abstract] [Full Text]

Bilirubin: A Natural Inhibitor of Vascular Smooth Muscle Cell Proliferation
Robert Öllinger, Martin Bilban, Anna Erat, Alberto Froio, James McDaid, Shivraj Tyagi, Eva Csizmadia, Aurelio V. Graça-Souza, Angela Liloia, Miguel P. Soares, Leo E. Otterbein, Anny Usheva, Kenichiro Yamashita, and Fritz H. Bach
Circulation 2005 112: 1030-1039. [Abstract] [Full Text]

Contribution of Cyclooxygenase-2 to Elevated Biosynthesis of Thromboxane A2 and Prostacyclin in Cigarette Smokers
Brendan F. McAdam, Daniel Byrne, Jason D. Morrow, and John A. Oates
Circulation 2005 112: 1024-1029. [Abstract] [Full Text]